TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/21 17:36 | 6/15/21 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S.dm | -1,095 | 73.03 | 0 | -15 | -72 | 6 | D | ||||||||||||||
1/13/21 16:08 | 1/11/21 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S.dm | -1,171 | 78.10 | 0 | -15 | -79 | 4 | D | ||||||||||||||
11/16/20 16:14 | 11/12/20 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S.dm | -1,323 | 50.87 | 0 | -26 | -93 | 2 | D | ||||||||||||||
10/15/20 16:20 | 10/13/20 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S.dm | -1,417 | 54.52 | 0 | -26 | -93 | 2 | D | ||||||||||||||
9/16/20 16:05 | 9/14/20 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S.dm | -1,288 | 49.52 | 0 | -26 | -93 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |